Displaying 1921 - 1940 of 4737
FTC Announces Second Economic Liberty Public Roundtable
Date
The Federal Trade Commission’s Economic Liberty Task Force announced today that it will hold its second roundtable in Washington, DC on Nov. 7, 2017, to examine empirical evidence on the effects of...
1709001 Informal Interpretation
Date
Rule
Form Instructions
Same process – follow up with the original hardcopies.
File
Original
(66.12 KB)
Federal Register Notice
Mars, Incorporated and VCA Inc.; Analysis To Aid Public Comment Proposed Consent Agreement
Date
FTC Acting Chairman Maureen K. Ohlhausen Announces Selection of Ian R. Conner as an Acting Deputy Director of the Bureau of Competition
Date
Acting Federal Trade Commission Chairman Maureen K. Ohlhausen announced today that she has selected Ian R. Conner, a partner in the Antitrust & Competition group at the law firm of Kirkland & Ellis...
Grifols, S.A., and Talecris Biotherapeutics Holdings Corp., In the Matter of
The FTC required Grifols, S.A., a manufacturer of plasma-derived drugs, to make significant divestitures as part of a settlement allowing Grifols to acquire a leading plasma-derived drug manufacturer, Talecris Biotherapeutics Holdings Corp. It resolves FTC charges that Grifols’ proposed acquisition of Talecris would be anticompetitive and would violate federal antitrust laws. As part of the settlement, Grifols will sell the Talecris fractionation facility in Melville, New York, and Grifols’ plasma collection centers in Mobile, Alabama, and Winston-Salem, North Carolina, to Kedrion S.p.A. Kedrion is a manufacturer of plasma-derived products in Europe and other markets, and will be a new entrant in the U.S. plasma-derived products industry. Grifols also will manufacture three plasma-derived products for Kedrion for several years under a manufacturing agreement. The FTC approved a final order on July 22, 2011.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
1010153
Docket Number
C-4322
Report
Conditional Pricing Practices – A Short Primer
Date
This paper reviews the economic literature on “conditional pricing practices.” Conditional pricing practices are pricing strategies in which a seller conditions its prices on factors such as volume...
File
Conditional Pricing Practices – A Short Primer
(234.49 KB)
1708008 Informal Interpretation
Date
Rule
Item 3, Item 5
We agree with you on #1; on #2, a note about additional anticipated acquisitions are always welcome, but especially important when the acquisitions are in the same or related industries.
File
Original
(123.41 KB)
FTC Final Order with Baxter International and Claris Lifesciences Preserves U.S. Competition for the Injectable Drugs Intravenous Fluconazole and Intravenous Milrinone
Date
Following a public comment period, the Federal Trade Commission has approved a final order designed to remedy the anticompetitive effects resulting from Baxter’s proposed $625 million acquisition of...
FTC Requires Mars to Divest 12 Veterinary Clinics as a Condition of Acquiring Pet Care Company VCA Inc.
Date
Mars, Incorporated has agreed to divest 12 veterinary clinics around the United States that provide specialty and emergency services to settle Federal Trade Commission charges that Mars’s $9.1 billion...
Baxter International Inc., Claris Lifesciences Limited, and Arjun Handa, In the Matter of
Baxter International Inc. and Claris Lifesciences Limited have agreed to divest two types of pharmaceutical products to settle charges that Baxter’s proposed $625 million acquisition of Claris’ injectable drugs business would (1) reduce current competition in the United States for the antifungal agent fluconazole in saline intravenous bags, which is used to treat fungal and yeast infections, and (2)reduce future competition in the U.S. market for intravenous milrinone, which dilates the blood vessels, lowers blood pressure and allows blood to flow more easily through the cardiovascular system. Under the FTC order, the parties will divest all of Claris’s rights to fluconazole in saline intravenous bags and milrinone in dextrose intravenous bags to New Jersey-based pharmaceutical company Renaissance Lakewood LLC. The order requires Baxter to supply Renaissance with fluconazole in saline intravenous bags and milrinone in dextrose intravenous bags for up to five years while transferring the manufacturing technology to Renaissance or its contract manufacturing designee. Baxter is also required to assist Renaissance in establishing its manufacturing capabilities and securing the necessary FDA approvals.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
171 0052
Report
Price Effects of a Merger: Evidence from a Physicians’ Market
Date
Physicians’ practices vary widely, as do their effectiveness and reimbursement. Using a merger of six orthopaedic groups in southeastern Pennsylvania, we find that such groups can generate large, anti...
File
1708007 Informal Interpretation
Date
Rule
Item 3
[Redacted], Yes, we’d consider these to be “other agreements between the parties,” so they should be included.
File
Original
(106.33 KB)
1708006 Informal Interpretation
Date
Rule
801.1, 801.10, 801.11
You need to begin by applying rules 801.10 and 801.11 to analyze the separate , not combined, holdings of each of A and B (unless they are spouses). It may be that one meets the size of person and the...
File
Original
(118.47 KB)
Statement of Federal Trade Commission’s Acting Director of the Bureau of Competition on the Agency's Review of Amazon.com, Inc.'s Acquisition of Whole Foods Market Inc.
Date
Bruce Hoffman, the Acting Director of the Federal Trade Commission’s Bureau of Competition, issued this statement on the Commission’s decision not to further pursue an investigation of Amazon.com, Inc...
1708005 Informal Interpretation
Date
Rule
803.7
The PNO has been asked this question before, and the unequivocal response has been that two filings for the same transaction may not be simultaneously active. The one year limitation in 803.7 is, in...
File
Original
(84.65 KB)
1708004 Informal Interpretation
Date
Rule
801.12
You look at the votes for director and B is its own UPE.
File
Original
(79.7 KB)
National Association of Animal Breeders, Inc. Agreed To Refrain From Adopting Rules that Restrict Competition Among Members
Date
The National Association of Animal Breeders, Inc., or NAAB – a non-profit trade association whose members compete to sell dairy cattle semen to U.S. dairy farms for artificial insemination of dairy...
Displaying 1921 - 1940 of 4737